Anzeige
Mehr »
Login
Donnerstag, 06.06.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Polymetall-Aktie: Bahnbrechendes Bohrloch könnte Metallknappheit lösen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Übersicht Suchergebnisse zum Thema TRANSMEDICS GROUP

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
28.05.TransMedics Group, Inc. - 8-K, Current Report1
17.05.TransMedics Group, Inc.: TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)128ANDOVER, Mass., May 17, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
► Artikel lesen
01.05.Transmedics Group Inc reports results for the quarter ended in March - Earnings Summary6
30.04.TransMedics Group, Inc. - 8-K, Current Report1
30.04.TransMedics Group GAAP EPS of $0.35 beats by $0.36, revenue of $96.85M beats by $13.08M4
30.04.TransMedics Group, Inc.: TransMedics Reports First Quarter 2024 Financial Results151ANDOVER, Mass., April 30, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
► Artikel lesen
29.04.TransMedics Group Q1 2024 Earnings Preview1
08.04.TransMedics Group, Inc.: TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)62ANDOVER, Mass., April 8, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
► Artikel lesen
19.03.TransMedics Group, Inc.: TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)96ANDOVER, Mass., March 19, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
► Artikel lesen
12.03.TransMedics Group, Inc. - 8-K, Current Report2
28.02.TransMedics Group, Inc. (TMDX) Q4 2023 Earnings Call Transcript2
27.02.TransMedics Group, Inc. - 10-K, Annual Report1
27.02.Why TransMedics Group Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket3
26.02.TransMedics Group GAAP EPS of $0.12 beats by $0.16, revenue of $81.2M beats by $12.7M13
26.02.TransMedics Group, Inc.: TransMedics Reports Fourth Quarter and Full Year 2023 Financial Results212ANDOVER, Mass., Feb. 26, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
► Artikel lesen
16.02.TransMedics Group, Inc.: TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)315ANDOVER, Mass., Feb. 16, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
► Artikel lesen
06.02.TransMedics Group, Inc. - 8-K, Current Report-
29.01.TransMedics Group, Inc. - 8-K, Current Report1
02.01.TransMedics Group, Inc. - 8-K, Current Report3
19.12.23TransMedics Group, Inc. - 8-K, Current Report1